HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Mesangiocapillary glomerulonephritis — Clinical Guidelines

Overview

Mesangiocapillary glomerulonephritis (MCGN) is a type of glomerulonephritis characterized by immune complex deposition in the mesangium, leading to glomerular damage and potential renal dysfunction 2 3.

Diagnosis

Renal Biopsy: Essential for definitive diagnosis, revealing characteristic histopathological features 2 3.

Normal Renal Function Parameters: Can occur despite underlying pathology, necessitating biopsy for confirmation 2.

C3 Nephritic Factor: Presence may correlate with MCGN, particularly in cases associated with partial lipodystrophy 2.

Management

No Specific Doses Mentioned: General management includes supportive care and monitoring of renal function 2 3.

Immunosuppressive Therapy: Consideration in severe cases, though specific drug classes and doses are not detailed in the provided abstracts 2 3.

Special Populations

Comorbidities: MCGN can coexist with conditions like partial lipodystrophy and Kartagener syndrome, requiring comprehensive evaluation 2 3.

Infection Considerations: Potential link between infections and MCGN pathogenesis noted, particularly in syndromic associations 3.

Key Recommendations

Perform Renal Biopsy for Diagnosis: Essential for confirming MCGN, especially in asymptomatic patients with suspected underlying pathology (Evidence: Moderate 2).

Monitor Renal Function Closely: Regular assessment of renal parameters is crucial despite normal clinical findings (Evidence: Moderate 2).

Consider Immunosuppressive Therapy in Severe Cases: Tailored management may be necessary for severe presentations, though specific guidelines are lacking (Evidence: Expert opinion 2 3).

References

1 De Angelis R, Cutolo M, Salaffi F, Restrepo JP, Grassi W. Quantitative and qualitative assessment of one rheumatology trainee's experience with a self-teaching programme in videocapillaroscopy. Clinical and experimental rheumatology 2009. link 2 Bennett WM, Bardana EJ, Wuepper K, Houghton D, Border WA, Götze O et al.. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. The American journal of medicine 1977. link90879-8) 3 Egbert BM, Schwartz E, Kempson RL. Kartagener syndrome: report of a case with mesangiocapillary glomerulonephritis. Archives of pathology & laboratory medicine 1977. link

Mesangiocapillary glomerulonephritis